Hashimoto’s thyroiditis is an autoimmune condition where the body produces antibodies that damage the thyroid gland, causing inflammation and hypothyroidism. It is the most common cause of hypothyroidism, leading to weight-gain, fatigue, hair loss, irregular or heavy menstrual bleeding, and more.

Once diagnosed, typical treatments are to replace the missing thyroid hormone, usually in the form of levothyroxine. Very little has changed in treatment strategy in decades, until the introduction of inducing native phages to target the body’s production of the two primary antibodies that are damaging the thyroid, anti-Thyroglobulin antibody, and anti-Thyroid peroxidase antibody.

Native phages are beneficial viruses that a person is born with and acquire throughout their lifetime. Researchers have found are over 32,000 different populations of phages living just in the healthy human gut. Although many are unaware that these phages exist, they are the most plentiful organism on the planet, by many magnitudes and play an important role in regulating the healthy microbiome populations of the body, and even help to regulate healthy genetic expression.

Recent advancements in phage-induction are opening new possibilities in targeting the two thyroid antibodies to enlist the assistance of these naturally occurring phages to seek out and stop or reduce the body’s inappropriate production of these antibodies. Clinical studies are ongoing at the Biologix Center for Optimum Health, in Franklin, Tennessee ever since the first case of early Hashimoto’s Thyroiditis was successfully treated with Thyroglobulin-antibody-induced Native Phage Therapy, restoring the patient to normal lab values of the antibody within five weeks. The patient reported positive feedback of having more energy and losing nine pounds without trying to do so. This first case was found and treated with the native phage therapy prior to beginning any conventional pharmaceutical treatments and relatively early in her condition, which may also have played a role in her rapid response to the native phage treatment. It is unknown whether more advanced cases would yield such positive results.

Recent research has speculated that various viral and bacterial infections may be a determining factor in the development of the antibodies causing Hashimoto’s. Here too phage-induction has already been well documented to often be more effective than conventional anti-viral and antibacterial treatments, especially when combined with a comprehensive wholistic treatment approach, as performed at the Biologix Center. Early before and after lab testing of using phage-induction to help the body eliminate various harmful viruses and bacteria has been documented. The following viruses have been reported as potentially causing the body to produce the damaging antibodies: Hepatitis C virus, human parvovirus B19, coxsackie virus and herpes virus, such as Epstein Barr virus. Other research reports bacterial populations in the human gut microbiome are (significantly reduced gut microbiome, and the relative abundances of Bacteroides, fecal Bacillus, Prevotella, and Lactobacillus also decreased), harmful microbiota like Bacteroides fragilis was significantly increased compared with the controls. Furthermore, the percentage of relevant abundance of other commensal bacteria such as Bacteroidetes, Bacteroides, and Lachnospiraceae was increased compared to people who do not have Hashimoto’s thyroiditis.

Customized native phage-induction strategies targeting the body’s production of, (1) the harmful antibodies, (2) the harmful viruses, and, (3) the harmful bacteria, in combination with comprehensive treatments to stimulate the optimum structural and functional integrity of the entire body, representing exciting treatment advancements for individuals with recently diagnosed Hashimoto’s thyroiditis.

The Biologix Center for Optimum Health, in Franklin, TN is accepting patients with previously considered treatment-resistant illnesses, including Hashimoto’s thyroiditis.